Phlegmanol C is primarily used in research settings for its bioactive properties, particularly in studies related to anti-inflammatory and antioxidant effects. It has shown potential in modulating cellular pathways involved in oxidative stress, making it a compound of interest in the development of therapeutic agents for chronic inflammatory conditions. Additionally, Phlegmanol C is investigated for its role in inhibiting certain enzymes linked to tumor progression, suggesting possible applications in oncology research. Due to its natural origin and structural complexity, it also serves as a lead compound in the synthesis of derivatives with enhanced biological activity. Its application remains largely within preclinical studies and drug discovery pipelines.